Approval · Notice of Compliance 29418 · 2022
ERVEBO: Notice of Compliance 29418
Issued November 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29418
- Date
- November 9, 2022
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERVEBO | 02532603 | Approved |
Medicinal ingredients
- EBOLA ZAIRE VACCINE (RVSV [DELTA] G-ZEBOV-GP, LIVE) 72,000,000 PFU per 1ML